Policy Integration in Developmental Neurotoxicology - PowerPoint PPT Presentation

1 / 20
About This Presentation
Title:

Policy Integration in Developmental Neurotoxicology

Description:

Policy keeping pace with new/emerging science and technology ... Science does not always advance in a linear or predictable fashion ... – PowerPoint PPT presentation

Number of Views:43
Avg rating:3.0/5.0
Slides: 21
Provided by: paull9
Category:

less

Transcript and Presenter's Notes

Title: Policy Integration in Developmental Neurotoxicology


1
Policy Integration in Developmental
Neurotoxicology 
Paul A. Locke, MPH, JD, DrPH Johns Hopkins
Bloomberg School of Public Health Center for
Alternatives to Animal Testing 13 March 2006
2
Overview of Presentation
3
Address three questions
  • What is policy integration?
  • What are current challenges facing, and
    opportunities for, policy integration?
  • What changes in approaches (in policy and in
    science) will smooth the way for timely,
    effective, meaningful DNT testing?

4
What is policy integration?
5
Policy integration
  • Policy and policy makers keeping pace with
    science
  • Science and scientists being responsive to policy
    needs and public demands

6
(No Transcript)
7
Policy keeping pace with new/emerging science and
technology
  • Event at cellular, subcellular, molecular,
    genetic levels
  • Conservation across species of fundamental
    processes and mechanisms
  • Genomics, proteomics, omics technologies
  • Decoding genome of humans and animals

8
Gene expression profiles--also called
fingerprints or signatures--of known toxicants or
toxicant families may, in the future, be used to
identify potential toxicity. In this example, the
genetic signature of test compound 1 is identical
to that of known peroxisome proliferators,
whereas that of test compound 2 does not match
any known toxicant family. (Source Rockett
Dix, Environmental Health Perspectives, 1999 Aug.
107(8) 651-8)
9
Science responsive to policy needs -- public
demands
  • Use fewer animals in testing
  • Deploy more alternatives and practice humane
    science
  • Conduct more testing to bridge toxic ignorance
    gap
  • Make testing cheaper, faster and more reliable
  • Design new tests that produce science that is as
    good as, or better than, science from old tests
  • Protect sensitive subpopulations such as fetuses,
    infants and children from toxic compounds
  • Harmonize tests across national borders

10
A complex situation
  • Science does not always advance in a linear or
    predictable fashion
  • Cannot always plan for or chart success
  • More research helps, but can create additional
    uncertainties
  • Some things very difficult to study
  • The public is rarely unified and does not speak
    with one voice
  • Simultaneous demand to achieve dissonant goals

11
Challenges and Opportunities
12
Challenges
  • Meeting the needs of different stakeholders
  • Working with less-than-optimal laws, regulations
    and policies
  • Working with different governmental institutions
    with nations and internationally
  • Refining new scientific techniques and knowledge
    and comparing it to existing science and
    technology

13
Opportunities
  • Frustration with current situation has fostered
    growing understanding of need for another
    approach to DNT
  • Humane science and alternatives
  • Model for similar situations?
  • Massive investment in science that holds great
    promise as alternatives
  • New laws, policies, seeking additional
    information about toxicology of compounds (e.g.,
    REACH, HPV program)

14
REACH
Registration, Evaluation, Assessment of Chemicals
  • 30,000 Chemicals
  • 40 Years
  • 11 Billion Dollars
  • 13 Million Animals
  • Base set of tests?

15
Chemical Toxicity Testing
  • Required for all NEW chemicals (TSCA) and
    pesticides (FIFRA)
  • Not required for chemicals on the market when
    TSCA was passed
  • Toxic ignorance gap -- 71 of chemicals lack
    basic screening data
  • Actions needed to fill gap
  • Get more and better information
  • Get information on more endpoints

16
Better policy integration
17
Data Sharing
  • Increase data generation
  • Data about DNT
  • Data about new techniques
  • integration with existing data
  • Assessment of strengths and weaknesses
  • Increase data sharing
  • Release data from in vitro and alternative tests
  • Make data available to risk assessors and the
    public

18
Validation
  • Validation has a policy aspect
  • Consider tiered testing schemes for screening and
    prioritization
  • Information generated by non-validated tests has
    merit
  • Validation of in vitro or alternative tests for
    which no animal test model is available
  • Link validation and regulatory acceptance

19
(No Transcript)
20
Conclusions
  • An effective DNT testing system will integrate
    policy and science
  • Meet competing societal demands
  • More information about DNT
  • Reduce use of animals
  • Take advantage of new science and technology
  • Humane science and alternatives provide a
    platform for effective policy integration and a
    DNT testing regime
Write a Comment
User Comments (0)
About PowerShow.com